TETANUS
Clinical trials for TETANUS explained in plain language.
Never miss a new study
Get alerted when new TETANUS trials appear
Sign up with your email to follow new studies for TETANUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New tetanus vaccine enters first human safety tests
⭐️ VACCINE ⭐️ OngoingThis early-stage trial is testing a new tetanus vaccine in 80 adults aged 18 and older. The study is randomized and double-blind, meaning neither participants nor doctors know who gets the new vaccine versus an existing one. The main goal is to check for side effects within the f…
Matched conditions: TETANUS
Phase: PHASE1 • Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 16, 2026 00:00 UTC
-
New infant vaccine aims to shield against three serious diseases
⭐️ VACCINE ⭐️ OngoingThis phase 3 study tests a new vaccine (DTacP) that protects infants from diphtheria, tetanus, and whooping cough. Around 2,900 healthy babies aged 2-3 months will receive the vaccine to check its safety and how well it triggers immunity. The trial compares different schedules an…
Matched conditions: TETANUS
Phase: PHASE3 • Sponsor: China National Biotec Group Company Limited • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:26 UTC
-
New tetanus shot enters human safety testing
Disease control ENROLLING_BY_INVITATIONThis early-stage study tests a new lab-made antibody injection against tetanus in 68 healthy adults aged 18-60. The main goal is to check safety and side effects, not to treat or prevent tetanus directly. Participants receive a single shot and are monitored for several weeks.
Matched conditions: TETANUS
Phase: PHASE1 • Sponsor: Lanzhou Institute of Biological Products Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC